Staged heart bypass plus TAVR versus TAVR alone
Part of Heart & circulation clinical trials.
This study compares doing a staged coronary bypass (revascularization) along with a valve procedure (TAVR) versus doing TAVR and medical treatment alone. It aims to see which approach better helps people with both aortic valve narrowing and coronary artery disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have symptomatic aortic valve stenosis and are getting TAVR as a planned procedure
- Your heart artery disease is significant (at least one coronary blockage about 70% or more) and can be treated with a stent (PCI)
- Your heart team believes you’re a good candidate for TAVR through the groin and that you would get a bypass if you were having open-heart surgery
- Your TAVR must have been successful through the groin within the last 96 hours, with no major complications like stroke or serious vessel injury
- You have not had a stent or planned stent around the time of TAVR, and you don’t plan surgery to bypass the blocked coronary artery at the same time
- You must be able to live safely with follow-up for about 5 years (no conditions that greatly shorten life expectancy)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a less invasive valve replacement (TAVR) with traditional open-heart surgery for people with a specific type of severe aortic valve narrowing (bicuspid valve). It aims to see which approach works better for those at intermediate or low surgical risk.
This study tests whether TAVI (a procedure to replace your heart valve without open-heart surgery) can be done safely at centers that do not have on-site heart surgery backup. It looks at how well patients do after the procedure, focusing on safety and recovery.
This study tests whether continuing a beta-blocker (a heart medication) improves outcomes for people having a planned TAVR (a minimally invasive heart-valve replacement). It may help doctors decide whether to keep or stop this medicine after the procedure.
This study looks at how well the new heart valve works after a TAVI procedure, using pressure measurements to see if blood flow improves. It aims to confirm that the treatment is effective for people with severe aortic stenosis.
This trial tests two types of replacement heart valves (self-expanding and balloon-expanding) in people who have severe aortic stenosis (tight heart valve) and an enlarged aorta (the main blood vessel from the heart). The goal is to see which valve type works better for these patients.
This study tests a catheter-based procedure to replace a narrowed aortic valve without traditional open-heart surgery. It's designed for patients who are at higher risk for surgery due to age, health conditions, or anatomy.
Hear when a new Aortic Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.